MiR-377 has been reported to function as a tumor suppressor via suppressing DNMT1 in pancreatic cancer cells [16], negatively regulated of E2F and MAP3K7/NF-κB signaling pathway in melanoma cells [19]. This evidence concerns the gene MAP3K7 and familial pancreatic carcinoma.